2023年美国糖尿病学会年会会议纪要:糖尿病与其他代谢性疾病学术进展  

Proceedings of the 2023 annual meeting of American Diabetes Association(ADA):Progress of Diabetes-related Cardiovascular Diseases

作　　者：毛王佳 宗冠男 高媛 闫姗 程晓芸[1] Mao Wangjia;Zong Guannan;Gao Yuan;Yan Shan;Cheng Xiaoyun(Department of Endocrinology and Metabolism,Shanghai Tenth People′s Hospital,School of Medicine,Tongji University,Shanghai 200072,China;Department of Endocrinology and Metabolism,Tongji Hospital,School of Medicine,Tongji University,Shanghai 200000,China;Department of Endocrinology,Guangrao County People′s Hospital of Dongying city,Dongying 257300,China)

机构地区：[1]同济大学附属第十人民医院内分泌科,上海200072 [2]同济大学附属同济医院内分泌科,上海200000 [3]广饶县人民医院内分泌科,东营257300

出　　处：《中华内分泌代谢杂志》2023年第11期994-998,共5页Chinese Journal of Endocrinology and Metabolism

摘　　要：第83届美国糖尿病学会(American Diabetes Association)学术会议于2023年6月23日至6月26日在美国圣地亚哥,以线上、线下相结合的形式召开。此次大会内容丰富,涉及糖尿病流行病学、糖尿病并发症、糖尿病及其相关代谢疾病治疗进展等多方面重要内容。本文主要对大会的重要奖项、糖尿病及其他代谢性疾病的研究进展进行概述。The 83rd American Diabetes Association(ADA)Academic Conference was held from 23 to 26 June,2023 in San Diego,U.S.A,in a combined online and offline format.The conference featured various aspects,including diabetes epidemiology,diabetes complications,and advances in the treatment of diabetes and related metabolic diseases.This article provides an overview of Banting awards and research advancements in diabetes and other metabolic diseases.

关 键 词：糖尿病 并发症/合并症 代谢性疾病 美国糖尿病学会 

分 类 号：R587.1[医药卫生—内分泌]